Share Price and Basic Stock Data
Last Updated: January 7, 2026, 10:11 pm
| PEG Ratio | 0.42 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Alankit Ltd operates within the Finance & Investments sector, with its current market capitalization reported at ₹291 Cr. The company’s share price stood at ₹10.7, reflecting a price-to-earnings (P/E) ratio of 13.9. Revenue trends indicate significant fluctuations, with reported sales of ₹312 Cr for the fiscal year ending March 2023, declining to ₹236 Cr in March 2024, before rebounding to ₹301 Cr in March 2025. The trailing twelve months (TTM) sales are recorded at ₹346 Cr, suggesting a recovery trajectory. Quarterly sales figures also displayed variability; for instance, from ₹148.18 Cr in March 2023, it declined to ₹43.32 Cr in September 2023, before increasing to ₹52.61 Cr in December 2023. These fluctuations hint at underlying operational challenges and market dynamics that the company faces in sustaining consistent revenue growth.
Profitability and Efficiency Metrics
Alankit Ltd’s profitability metrics showcase a mixed performance. The operating profit margin (OPM) was reported at 4.27%, indicating a low level of operational efficiency compared to industry standards. Notably, the company recorded a net profit of ₹21 Cr, translating to a net profit margin of 7.19% for the fiscal year ending March 2025. However, the OPM reflected a decline from 11% in March 2024, emphasizing the need for improved cost management. The return on equity (ROE) stood at 7.56%, while the return on capital employed (ROCE) was recorded at 11.3%, both of which are relatively modest compared to typical sector benchmarks. The interest coverage ratio (ICR) of 13.34x indicates a healthy ability to meet interest obligations, although the company must enhance its operational profitability to leverage this financial strength effectively.
Balance Sheet Strength and Financial Ratios
The balance sheet of Alankit Ltd reflects a cautious approach towards leverage, with total borrowings recorded at ₹21 Cr against reserves of ₹280 Cr. The current ratio of 2.16x indicates a strong liquidity position, allowing the company to cover short-term liabilities effectively. However, the debt-to-equity ratio stands at a modest 0.03, suggesting minimal reliance on debt financing. Financial ratios such as the price-to-book value (P/BV) ratio of 1.26x indicate that the stock may be trading at a reasonable valuation compared to its net assets. The company’s book value per share was reported at ₹10.94, which aligns with the share price and signifies stability. However, the enterprise value (EV) of ₹379.17 Cr, coupled with the EV to EBITDA ratio of 7.42x, suggests that while the company has a solid asset base, its operational cash generation needs to improve to enhance shareholder value.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Alankit Ltd shows a predominant stake held by promoters at 54.14%, reflecting strong internal confidence in the company’s future. Foreign institutional investors (FIIs) hold a minimal stake of 0.37%, which may indicate a lack of significant international interest in the stock. Domestic institutional investors (DIIs) have a negligible stake of 0.01%, suggesting limited institutional backing. The total number of shareholders rose significantly to 1,14,068, reflecting increased retail participation. This increase in shareholders, especially in the last quarter of 2023, may be indicative of growing investor interest amidst the company’s recovery in sales and profitability metrics. However, the relatively low institutional participation could pose challenges in terms of perceived corporate governance and market confidence.
Outlook, Risks, and Final Insight
Looking ahead, Alankit Ltd faces both opportunities and challenges. The recovery in sales and profitability metrics indicates potential for growth; however, the volatility in quarterly performance raises concerns regarding operational consistency. Risks include fluctuating revenues and low operating margins, which could hinder long-term growth. The company’s low debt levels provide a buffer, but it must enhance its operational efficiency to unlock value. Strengths lie in its strong liquidity position and a solid reserve base, which can be leveraged for strategic initiatives. Overall, the path forward will require focused efforts on improving operational efficiency and enhancing investor confidence to capitalize on the recovery trend. The company’s ability to maintain momentum in sales growth while managing costs effectively will be crucial for sustained performance in the coming quarters.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 11.7 Cr. | 40.0 | 61.5/36.4 | 46.9 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,451 Cr. | 307 | 484/280 | 15.8 | 111 | 0.33 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 30.2 Cr. | 0.43 | 1.65/0.38 | 4.19 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 5.04 Cr. | 10.2 | 11.6/8.25 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 20.8 Cr. | 40.5 | 69.9/38.6 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 7,299.15 Cr | 1,354.55 | 76.89 | 3,844.57 | 0.35% | 21.71% | 14.20% | 7.28 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.19 | 116.10 | 148.18 | 48.62 | 43.32 | 52.61 | 91.16 | 61.93 | 64.35 | 72.77 | 102.01 | 90.78 | 80.09 |
| Expenses | 27.86 | 105.15 | 139.92 | 43.26 | 38.70 | 49.05 | 80.79 | 53.72 | 58.94 | 66.14 | 89.53 | 95.33 | 76.67 |
| Operating Profit | -14.67 | 10.95 | 8.26 | 5.36 | 4.62 | 3.56 | 10.37 | 8.21 | 5.41 | 6.63 | 12.48 | -4.55 | 3.42 |
| OPM % | -111.22% | 9.43% | 5.57% | 11.02% | 10.66% | 6.77% | 11.38% | 13.26% | 8.41% | 9.11% | 12.23% | -5.01% | 4.27% |
| Other Income | -36.85 | -6.81 | 2.08 | 2.45 | 2.47 | 5.76 | 1.16 | 3.11 | 3.85 | 1.95 | 3.52 | 16.93 | 5.58 |
| Interest | 0.49 | 0.52 | 0.13 | 0.25 | 0.60 | 0.56 | -0.29 | 0.86 | 0.95 | 0.97 | 1.05 | 0.59 | 0.84 |
| Depreciation | 1.90 | 1.97 | 2.47 | 1.94 | 1.91 | 1.88 | 1.94 | 1.90 | 2.16 | 2.77 | 3.56 | 3.27 | 3.31 |
| Profit before tax | -53.91 | 1.65 | 7.74 | 5.62 | 4.58 | 6.88 | 9.88 | 8.56 | 6.15 | 4.84 | 11.39 | 8.52 | 4.85 |
| Tax % | -7.81% | -161.21% | 27.52% | 13.70% | 44.54% | -18.02% | 34.62% | 12.03% | 40.49% | -7.44% | 53.73% | 30.05% | 7.42% |
| Net Profit | -49.69 | 4.31 | 5.60 | 4.85 | 2.54 | 8.12 | 6.47 | 7.53 | 3.67 | 5.20 | 5.27 | 5.96 | 4.49 |
| EPS in Rs | -3.24 | 0.24 | 0.21 | 0.21 | 0.09 | 0.36 | 0.24 | 0.27 | 0.12 | 0.19 | 0.16 | 0.19 | 0.16 |
Last Updated: January 2, 2026, 1:34 pm
Below is a detailed analysis of the quarterly data for Alankit Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 80.09 Cr.. The value appears to be declining and may need further review. It has decreased from 90.78 Cr. (Jun 2025) to 80.09 Cr., marking a decrease of 10.69 Cr..
- For Expenses, as of Sep 2025, the value is 76.67 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 95.33 Cr. (Jun 2025) to 76.67 Cr., marking a decrease of 18.66 Cr..
- For Operating Profit, as of Sep 2025, the value is 3.42 Cr.. The value appears strong and on an upward trend. It has increased from -4.55 Cr. (Jun 2025) to 3.42 Cr., marking an increase of 7.97 Cr..
- For OPM %, as of Sep 2025, the value is 4.27%. The value appears strong and on an upward trend. It has increased from -5.01% (Jun 2025) to 4.27%, marking an increase of 9.28%.
- For Other Income, as of Sep 2025, the value is 5.58 Cr.. The value appears to be declining and may need further review. It has decreased from 16.93 Cr. (Jun 2025) to 5.58 Cr., marking a decrease of 11.35 Cr..
- For Interest, as of Sep 2025, the value is 0.84 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.59 Cr. (Jun 2025) to 0.84 Cr., marking an increase of 0.25 Cr..
- For Depreciation, as of Sep 2025, the value is 3.31 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.27 Cr. (Jun 2025) to 3.31 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Sep 2025, the value is 4.85 Cr.. The value appears to be declining and may need further review. It has decreased from 8.52 Cr. (Jun 2025) to 4.85 Cr., marking a decrease of 3.67 Cr..
- For Tax %, as of Sep 2025, the value is 7.42%. The value appears to be improving (decreasing) as expected. It has decreased from 30.05% (Jun 2025) to 7.42%, marking a decrease of 22.63%.
- For Net Profit, as of Sep 2025, the value is 4.49 Cr.. The value appears to be declining and may need further review. It has decreased from 5.96 Cr. (Jun 2025) to 4.49 Cr., marking a decrease of 1.47 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.16. The value appears to be declining and may need further review. It has decreased from 0.19 (Jun 2025) to 0.16, marking a decrease of 0.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:41 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3 | 31 | 85 | 105 | 130 | 156 | 115 | 128 | 312 | 236 | 301 | 346 |
| Expenses | 3 | 22 | 64 | 76 | 110 | 132 | 96 | 117 | 299 | 210 | 268 | 328 |
| Operating Profit | -1 | 9 | 21 | 29 | 21 | 24 | 19 | 11 | 13 | 26 | 33 | 18 |
| OPM % | -27% | 28% | 25% | 28% | 16% | 15% | 17% | 9% | 4% | 11% | 11% | 5% |
| Other Income | 2 | 0 | 2 | 4 | 8 | 7 | 3 | 9 | -40 | 12 | 12 | 28 |
| Interest | 0 | 0 | 1 | 3 | 2 | 3 | 4 | 3 | 2 | 3 | 4 | 3 |
| Depreciation | 0 | 3 | 1 | 4 | 4 | 5 | 4 | 9 | 8 | 8 | 10 | 13 |
| Profit before tax | 1 | 5 | 20 | 26 | 22 | 23 | 15 | 8 | -38 | 27 | 31 | 30 |
| Tax % | 64% | 29% | 35% | 16% | 35% | 38% | 24% | 66% | -8% | 19% | 30% | |
| Net Profit | 0 | 4 | 13 | 22 | 14 | 14 | 11 | 3 | -35 | 22 | 22 | 21 |
| EPS in Rs | 0.03 | 0.26 | 0.93 | 1.52 | 0.98 | 0.98 | 0.69 | 0.17 | -1.50 | 0.80 | 0.73 | 0.70 |
| Dividend Payout % | 193% | 39% | 22% | 13% | 20% | 20% | 29% | 121% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 225.00% | 69.23% | -36.36% | 0.00% | -21.43% | -72.73% | -1266.67% | 162.86% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -155.77% | -105.59% | 36.36% | -21.43% | -51.30% | -1193.94% | 1429.52% | -162.86% |
Alankit Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 61% |
| 5 Years: | 14% |
| 3 Years: | 33% |
| TTM: | 32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 52% |
| 5 Years: | 12% |
| 3 Years: | 110% |
| TTM: | -18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -6% |
| 3 Years: | 1% |
| 1 Year: | -46% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 9% |
| 3 Years: | 10% |
| Last Year: | 8% |
Last Updated: September 4, 2025, 10:40 pm
Balance Sheet
Last Updated: December 4, 2025, 12:55 am
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 14 | 14 | 14 | 14 | 14 | 14 | 22 | 27 | 27 | 27 |
| Reserves | 24 | 28 | 33 | 49 | 59 | 73 | 80 | 119 | 139 | 249 | 270 | 280 |
| Borrowings | 0 | 0 | 5 | 5 | 14 | 13 | 14 | 21 | 13 | 44 | 12 | 21 |
| Other Liabilities | 1 | 16 | 26 | 58 | 53 | 71 | 57 | 107 | 128 | 211 | 116 | 116 |
| Total Liabilities | 33 | 51 | 78 | 126 | 140 | 172 | 165 | 261 | 302 | 531 | 425 | 445 |
| Fixed Assets | 1 | 28 | 28 | 36 | 55 | 50 | 68 | 87 | 56 | 50 | 81 | 77 |
| CWIP | 0 | 0 | 0 | 18 | 16 | 18 | 1 | 0 | 0 | 9 | 0 | 0 |
| Investments | 1 | 0 | 2 | 1 | 1 | 0 | 1 | 12 | 11 | 21 | 36 | 40 |
| Other Assets | 30 | 23 | 49 | 70 | 68 | 104 | 97 | 161 | 236 | 451 | 308 | 328 |
| Total Assets | 33 | 51 | 78 | 126 | 140 | 172 | 165 | 261 | 302 | 531 | 425 | 445 |
Below is a detailed analysis of the balance sheet data for Alankit Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00 Cr..
- For Reserves, as of Sep 2025, the value is 280.00 Cr.. The value appears strong and on an upward trend. It has increased from 270.00 Cr. (Mar 2025) to 280.00 Cr., marking an increase of 10.00 Cr..
- For Borrowings, as of Sep 2025, the value is 21.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 12.00 Cr. (Mar 2025) to 21.00 Cr., marking an increase of 9.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 116.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 116.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 445.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 425.00 Cr. (Mar 2025) to 445.00 Cr., marking an increase of 20.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 77.00 Cr.. The value appears to be declining and may need further review. It has decreased from 81.00 Cr. (Mar 2025) to 77.00 Cr., marking a decrease of 4.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Mar 2025) to 40.00 Cr., marking an increase of 4.00 Cr..
- For Other Assets, as of Sep 2025, the value is 328.00 Cr.. The value appears strong and on an upward trend. It has increased from 308.00 Cr. (Mar 2025) to 328.00 Cr., marking an increase of 20.00 Cr..
- For Total Assets, as of Sep 2025, the value is 445.00 Cr.. The value appears strong and on an upward trend. It has increased from 425.00 Cr. (Mar 2025) to 445.00 Cr., marking an increase of 20.00 Cr..
Notably, the Reserves (280.00 Cr.) exceed the Borrowings (21.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -1.00 | 9.00 | 16.00 | 24.00 | 7.00 | 11.00 | 5.00 | -10.00 | 0.00 | -18.00 | 21.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 106 | 69 | 54 | 49 | 78 | 89 | 110 | 131 | 80 | 111 | 72 |
| Inventory Days | 1,297 | 247 | 76 | 142 | 288 | 57 | 119 | 62 | 9 | 31 | 19 |
| Days Payable | 288 | 59 | 92 | 1,274 | 561 | 274 | 316 | 221 | 47 | 153 | 56 |
| Cash Conversion Cycle | 1,114 | 257 | 38 | -1,083 | -196 | -129 | -88 | -28 | 41 | -10 | 35 |
| Working Capital Days | 2,506 | 91 | 26 | 4 | 27 | 86 | 147 | 14 | 105 | -54 | 77 |
| ROCE % | 16% | 50% | 47% | 30% | 24% | 17% | 8% | 8% | 11% | 11% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 0.73 | 0.96 | -2.07 | 0.16 | 0.77 |
| Diluted EPS (Rs.) | 0.73 | 0.96 | -2.07 | 0.16 | 0.77 |
| Cash EPS (Rs.) | 1.18 | 1.09 | -1.19 | 0.80 | 1.08 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 10.94 | 10.95 | 8.07 | 10.12 | 6.88 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 10.94 | 10.95 | 8.07 | 10.12 | 6.88 |
| Revenue From Operations / Share (Rs.) | 11.10 | 8.69 | 13.88 | 8.96 | 8.04 |
| PBDIT / Share (Rs.) | 1.88 | 1.32 | 0.97 | 1.31 | 1.44 |
| PBIT / Share (Rs.) | 1.50 | 1.04 | 0.59 | 0.69 | 1.13 |
| PBT / Share (Rs.) | 1.14 | 0.99 | -1.71 | 0.58 | 1.02 |
| Net Profit / Share (Rs.) | 0.79 | 0.81 | -1.56 | 0.20 | 0.77 |
| NP After MI And SOA / Share (Rs.) | 0.73 | 0.79 | -1.50 | 0.16 | 0.77 |
| PBDIT Margin (%) | 16.96 | 15.17 | 7.00 | 14.56 | 17.91 |
| PBIT Margin (%) | 13.51 | 11.91 | 4.28 | 7.76 | 14.09 |
| PBT Margin (%) | 10.27 | 11.43 | -12.30 | 6.55 | 12.67 |
| Net Profit Margin (%) | 7.19 | 9.32 | -11.26 | 2.24 | 9.62 |
| NP After MI And SOA Margin (%) | 6.59 | 9.14 | -10.82 | 1.83 | 9.62 |
| Return on Networth / Equity (%) | 6.69 | 7.80 | -20.95 | 1.76 | 11.74 |
| Return on Capital Employeed (%) | 12.37 | 9.17 | 6.67 | 5.84 | 12.60 |
| Return On Assets (%) | 4.67 | 4.05 | -11.16 | 0.90 | 6.69 |
| Long Term Debt / Equity (X) | 0.01 | 0.02 | 0.04 | 0.05 | 0.09 |
| Total Debt / Equity (X) | 0.03 | 0.15 | 0.08 | 0.15 | 0.14 |
| Asset Turnover Ratio (%) | 0.63 | 0.56 | 1.11 | 0.60 | 0.68 |
| Current Ratio (X) | 2.16 | 1.16 | 2.09 | 1.37 | 2.46 |
| Quick Ratio (X) | 2.08 | 1.13 | 2.04 | 1.26 | 2.34 |
| Inventory Turnover Ratio (X) | 42.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 121.32 | 25.81 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 25.84 | 18.48 |
| Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | -21.32 | 74.19 |
| Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 74.16 | 81.52 |
| Interest Coverage Ratio (X) | 13.34 | 31.83 | 13.43 | 11.95 | 12.61 |
| Interest Coverage Ratio (Post Tax) (X) | 8.21 | 20.57 | 10.20 | 2.84 | 7.78 |
| Enterprise Value (Cr.) | 379.17 | 477.53 | 180.29 | 198.90 | 237.14 |
| EV / Net Operating Revenue (X) | 1.26 | 2.03 | 0.57 | 1.55 | 2.06 |
| EV / EBITDA (X) | 7.42 | 13.35 | 8.26 | 10.66 | 11.51 |
| MarketCap / Net Operating Revenue (X) | 1.25 | 2.04 | 0.52 | 1.47 | 1.97 |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | -21.32 | 74.18 |
| Price / BV (X) | 1.26 | 1.74 | 1.02 | 1.42 | 2.40 |
| Price / Net Operating Revenue (X) | 1.25 | 2.04 | 0.52 | 1.47 | 1.97 |
| EarningsYield | 0.05 | 0.04 | -0.20 | 0.01 | 0.04 |
After reviewing the key financial ratios for Alankit Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 5. It has decreased from 0.96 (Mar 24) to 0.73, marking a decrease of 0.23.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 5. It has decreased from 0.96 (Mar 24) to 0.73, marking a decrease of 0.23.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.18. This value is below the healthy minimum of 3. It has increased from 1.09 (Mar 24) to 1.18, marking an increase of 0.09.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 10.94. It has decreased from 10.95 (Mar 24) to 10.94, marking a decrease of 0.01.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 10.94. It has decreased from 10.95 (Mar 24) to 10.94, marking a decrease of 0.01.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 11.10. It has increased from 8.69 (Mar 24) to 11.10, marking an increase of 2.41.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.88. This value is below the healthy minimum of 2. It has increased from 1.32 (Mar 24) to 1.88, marking an increase of 0.56.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.50. This value is within the healthy range. It has increased from 1.04 (Mar 24) to 1.50, marking an increase of 0.46.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.14. This value is within the healthy range. It has increased from 0.99 (Mar 24) to 1.14, marking an increase of 0.15.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 2. It has decreased from 0.81 (Mar 24) to 0.79, marking a decrease of 0.02.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 2. It has decreased from 0.79 (Mar 24) to 0.73, marking a decrease of 0.06.
- For PBDIT Margin (%), as of Mar 25, the value is 16.96. This value is within the healthy range. It has increased from 15.17 (Mar 24) to 16.96, marking an increase of 1.79.
- For PBIT Margin (%), as of Mar 25, the value is 13.51. This value is within the healthy range. It has increased from 11.91 (Mar 24) to 13.51, marking an increase of 1.60.
- For PBT Margin (%), as of Mar 25, the value is 10.27. This value is within the healthy range. It has decreased from 11.43 (Mar 24) to 10.27, marking a decrease of 1.16.
- For Net Profit Margin (%), as of Mar 25, the value is 7.19. This value is within the healthy range. It has decreased from 9.32 (Mar 24) to 7.19, marking a decrease of 2.13.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.59. This value is below the healthy minimum of 8. It has decreased from 9.14 (Mar 24) to 6.59, marking a decrease of 2.55.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.69. This value is below the healthy minimum of 15. It has decreased from 7.80 (Mar 24) to 6.69, marking a decrease of 1.11.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.37. This value is within the healthy range. It has increased from 9.17 (Mar 24) to 12.37, marking an increase of 3.20.
- For Return On Assets (%), as of Mar 25, the value is 4.67. This value is below the healthy minimum of 5. It has increased from 4.05 (Mar 24) to 4.67, marking an increase of 0.62.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 0.15 (Mar 24) to 0.03, marking a decrease of 0.12.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.63. It has increased from 0.56 (Mar 24) to 0.63, marking an increase of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 2.16. This value is within the healthy range. It has increased from 1.16 (Mar 24) to 2.16, marking an increase of 1.00.
- For Quick Ratio (X), as of Mar 25, the value is 2.08. This value exceeds the healthy maximum of 2. It has increased from 1.13 (Mar 24) to 2.08, marking an increase of 0.95.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 42.21. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 42.21, marking an increase of 42.21.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 13.34. This value is within the healthy range. It has decreased from 31.83 (Mar 24) to 13.34, marking a decrease of 18.49.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.21. This value is within the healthy range. It has decreased from 20.57 (Mar 24) to 8.21, marking a decrease of 12.36.
- For Enterprise Value (Cr.), as of Mar 25, the value is 379.17. It has decreased from 477.53 (Mar 24) to 379.17, marking a decrease of 98.36.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 2.03 (Mar 24) to 1.26, marking a decrease of 0.77.
- For EV / EBITDA (X), as of Mar 25, the value is 7.42. This value is within the healthy range. It has decreased from 13.35 (Mar 24) to 7.42, marking a decrease of 5.93.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.25. This value is within the healthy range. It has decreased from 2.04 (Mar 24) to 1.25, marking a decrease of 0.79.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.74 (Mar 24) to 1.26, marking a decrease of 0.48.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.25. This value is within the healthy range. It has decreased from 2.04 (Mar 24) to 1.25, marking a decrease of 0.79.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alankit Ltd:
- Net Profit Margin: 7.19%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.37% (Industry Average ROCE: 21.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.69% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 8.21
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.08
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 13.8 (Industry average Stock P/E: 76.89)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.19%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | 205-208, Anarkali Complex, New Delhi Delhi 110055 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashok Kumar Sinha | Chairman & Ind.Director |
| Mr. Ankit Agarwal | Managing Director |
| Mrs. Preeti Chadha | Non Executive Director |
| Mrs. Meera Lal | Non Executive Director |
| Mr. Raja Gopal Reddy Guduru | Non Executive Director |
| Ms. Meenu Agrawal | Independent Director |
FAQ
What is the intrinsic value of Alankit Ltd?
Alankit Ltd's intrinsic value (as of 07 January 2026) is ₹9.62 which is 9.25% lower the current market price of ₹10.60, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹290 Cr. market cap, FY2025-2026 high/low of ₹22.0/10.3, reserves of ₹280 Cr, and liabilities of ₹445 Cr.
What is the Market Cap of Alankit Ltd?
The Market Cap of Alankit Ltd is 290 Cr..
What is the current Stock Price of Alankit Ltd as on 07 January 2026?
The current stock price of Alankit Ltd as on 07 January 2026 is ₹10.6.
What is the High / Low of Alankit Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Alankit Ltd stocks is ₹22.0/10.3.
What is the Stock P/E of Alankit Ltd?
The Stock P/E of Alankit Ltd is 13.8.
What is the Book Value of Alankit Ltd?
The Book Value of Alankit Ltd is 11.3.
What is the Dividend Yield of Alankit Ltd?
The Dividend Yield of Alankit Ltd is 0.00 %.
What is the ROCE of Alankit Ltd?
The ROCE of Alankit Ltd is 11.3 %.
What is the ROE of Alankit Ltd?
The ROE of Alankit Ltd is 7.56 %.
What is the Face Value of Alankit Ltd?
The Face Value of Alankit Ltd is 1.00.